Could polygenic risk scores be useful in psychiatry?: a review

GK Murray, T Lin, J Austin, JJ McGrath, IB Hickie… - JAMA …, 2021 - jamanetwork.com
Importance Polygenic risk scores (PRS) are predictors of the genetic susceptibility to
diseases, calculated for individuals as weighted counts of thousands of risk variants in which …

Risk factors for suicidal thoughts and behaviors: A meta-analysis of 50 years of research.

JC Franklin, JD Ribeiro, KR Fox, KH Bentley… - Psychological …, 2017 - psycnet.apa.org
Suicidal thoughts and behaviors (STBs) are major public health problems that have not
declined appreciably in several decades. One of the first steps to improving the prevention …

Antipsychotics: mechanisms underlying clinical response and side-effects and novel treatment approaches based on pathophysiology

SJ Kaar, S Natesan, R Mccutcheon, OD Howes - Neuropharmacology, 2020 - Elsevier
Antipsychotic drugs are central to the treatment of schizophrenia and other psychotic
disorders but are ineffective for some patients and associated with side-effects and …

What is the risk‐benefit ratio of long‐term antipsychotic treatment in people with schizophrenia?

CU Correll, JM Rubio, JM Kane - World Psychiatry, 2018 - Wiley Online Library
The long‐term benefit‐to‐risk ratio of sustained antipsychotic treatment for schizophrenia
has recently been questioned. In this paper, we critically examine the literature on the long …

Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies

PM Haddad, C Brain, J Scott - Patient related outcome measures, 2014 - Taylor & Francis
Nonadherence with medication occurs in all chronic medical disorders. It is a particular
challenge in schizophrenia due to the illness's association with social isolation, stigma, and …

Why do psychiatric patients stop antipsychotic medication? A systematic review of reasons for nonadherence to medication in patients with serious mental illness

DI Velligan, M Sajatovic, A Hatch… - Patient preference …, 2017 - Taylor & Francis
Background Antipsychotic medication reduces the severity of serious mental illness (SMI)
and improves patient outcomes only when medicines were taken as prescribed …

[HTML][HTML] Adherence to antipsychotic medication in bipolar disorder and schizophrenic patients: a systematic review

S García, M Martínez-Cengotitabengoa… - Journal of clinical …, 2016 - journals.lww.com
Antipsychotics are the drugs prescribed to treat psychotic disorders; however, patients often
fail to adhere to their treatment, and this has a severe negative effect on prognosis in these …

[HTML][HTML] The use of long-acting injectable antipsychotics in schizophrenia: evaluating the evidence

CU Correll, L Citrome, PM Haddad… - The Journal of clinical …, 2016 - psychiatrist.com
METHODS A group of 8 experts on the management of schizophrenia and LAIs met to
evaluate the evidence and to develop a set of recommendations regarding the clinical use …

Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review

K Higashi, G Medic, KJ Littlewood… - Therapeutic …, 2013 - journals.sagepub.com
Background: Nonadherence to medication is a recognized problem and may be the most
challenging aspect of treatment. Methods: We performed a systematic review of factors that …

A systematic review of factors influencing adherence to antipsychotic medication in schizophrenia-spectrum disorders

KV Sendt, DK Tracy, S Bhattacharyya - Psychiatry research, 2015 - Elsevier
Adherence to antipsychotics improves outcome in schizophrenia. There is a lack of
consensus on which factors most influence adherence behaviour and methodological …